chartexchange

Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results

GlobeNewswire Inc. | Nov 5, 2026 4:05 PM EST

DEER PARK, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended September 30, 2026.

Read original article